TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05355402 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05355402 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05355402 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04743414 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06358378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05164952 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05601752 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05905328 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05217381 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06649955 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT06518863 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT06550674 — Predictive Biomarker (PRD): MBD4 mRNA
Genes: MBD4; MED1
Study NCT04955743 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05374759 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05209568 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05986539 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05986539 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05603988 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06375330 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04745871 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06030895 — Predictive Biomarker (PRD): ATG10 mRNA
Genes: ATG10; APG10L; PP12616
Study NCT06030895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06529718 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05481827 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06662994 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05045846 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06029556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05539716 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04966741 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT04966741 — Predictive Biomarker (PRD): PCSK1 mRNA
Genes: PCSK1; NEC1
Study NCT04966741 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study NCT06442709 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT06523777 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05012306 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05325892 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04529265 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04654468 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04836156 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04836156 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04743505 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04125524 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04125524 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06193486 — Predictive Biomarker (PRD): PSCA mRNA
Genes: PSCA; UNQ206/PRO232
Study NCT05365711 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT06554613 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05295680 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT05617209 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT05617209 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT06041529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05633615 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05850273 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05850273 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study NCT05850273 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT06463964 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04936672 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05693844 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT05693844 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00002311 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05436223 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05075057 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05275491 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05275491 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05569811 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT05569811 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05569811 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04918940 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04918940 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04793061 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05403333 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05857202 — Predictive Biomarker (PRD): GPX1 mRNA
Genes: GPX1
Study NCT05857202 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05857202 — Safety Biomarker (SAF): Interleukin 1
Study NCT06694701 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT06694701 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05801523 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04766424 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04876664 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06707753 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06707753 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06709859 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04679870 — Predictive Biomarker (PRD): LOXL2 mRNA
Genes: LOXL2
Study NCT04923880 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06096233 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00000711 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05905822 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06744465 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05350813 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01430429 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT05033613 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06745648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05649124 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study NCT06338059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06745544 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06745544 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06744335 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06744335 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05170555 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05291143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06507553 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT05578872 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05578872 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04224779 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05294913 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06377332 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT06377332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06377332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06377332 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06377332 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT06377332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06377332 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04824183 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05948930 — Predictive Biomarker (PRD): NAPA mRNA
Genes: NAPA; SNAPA
Study NCT05316129 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05995522 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT06201572 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05463679 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study NCT06012487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06205303 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05069636 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06043726 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06529289 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06532019 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06581068 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT05534087 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05797896 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05174884 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT05267106 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT06287918 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05189457 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT05551377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05563077 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05976438 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05386485 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06168409 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05323110 — Predictive Biomarker (PRD): TNFSF14 mRNA
Genes: TNFSF14; HVEML; LIGHT; UNQ391/PRO726
Study NCT06015633 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06349707 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05592470 — Predictive Biomarker (PRD): COMMD7 mRNA
Genes: COMMD7; C20orf92
Study NCT06164795 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05205200 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05205200 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06544525 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT05242159 — Predictive Biomarker (PRD): ANXA2 mRNA
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT05146973 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05346224 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05346224 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05346224 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT06343051 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05075785 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06402084 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06402084 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06402084 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06402084 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06402084 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06497075 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05233267 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05442333 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05585138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05170256 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05659056 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06062927 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05566886 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06055153 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05090410 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT05090410 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05882175 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT05558722 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05558722 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT05558722 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05663086 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06082947 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06082947 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06082947 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05011422 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05189015 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06672380 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000650 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06344793 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06344793 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06378658 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06378658 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06378658 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06285370 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT05720533 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05117892 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04990336 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT05221827 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05387265 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05567068 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05776186 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05351593 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06164899 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06173518 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05446181 — Predictive Biomarker (PRD): CLIC1 mRNA
Genes: CLIC1; G6; NCC27
Study NCT06243354 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05847283 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05423730 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06575309 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT06575309 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03814109 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05093335 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05489549 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05489549 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT06565338 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05552586 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06624046 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06674382 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT06674109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06674109 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06380933 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05957367 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT06543394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06393101 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06157307 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06321484 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06157060 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06530745 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06083935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06083935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06083935 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05000736 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05000736 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05465746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04974047 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05671757 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05384665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05240950 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05240950 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06273540 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05355298 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT06196697 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00001064 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06511986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05608564 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT05608564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05608564 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05608564 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05433298 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05433298 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05154487 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05154487 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06441864 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT05349019 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT04686734 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05855070 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05718791 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT05105165 — Predictive Biomarker (PRD): PNOC mRNA
Genes: PNOC; OFQ
Study NCT04995965 — Predictive Biomarker (PRD): CPE mRNA
Genes: CPE
Study NCT04838444 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06137066 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT05220800 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT05220800 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05713305 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04685590 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05438485 — Predictive Biomarker (PRD): MMAB mRNA
Genes: MMAB
Study NCT06671847 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06681740 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06688032 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04947657 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06262477 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05140525 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05827614 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT05632406 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05661357 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06392828 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04809467 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05494320 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study NCT05494320 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MRP2
Genes: ABCC2; DJS; cMRP